MEROPENEM INHIBITION OF ENDOTOXIN RELEASE FROM ESCHERICHIA-COLI

Citation
Ba. Cunha et al., MEROPENEM INHIBITION OF ENDOTOXIN RELEASE FROM ESCHERICHIA-COLI, Advances in therapy, 14(4), 1997, pp. 168-171
Citations number
7
Categorie Soggetti
Medicine, Research & Experimental","Pharmacology & Pharmacy
Journal title
ISSN journal
0741238X
Volume
14
Issue
4
Year of publication
1997
Pages
168 - 171
Database
ISI
SICI code
0741-238X(1997)14:4<168:MIOERF>2.0.ZU;2-V
Abstract
Gram-negative sepsis may cause organ dysfunction and damage. Organ dam age in gram-negative sepsis is caused by endotoxin and other inflammat ory mediators, such as cyokines. Antibiotics limit the spread of infec tion in sepsis but do not eliminate cytokine-mediated cellular damage. Most beta-lactam antibiotics increase endotoxin release from gram-neg ative bacteria, thereby potentiating tissue damage. Aminoglycosides, i mipenem, and polymyxin B inhibit endotoxin release by gram-negative ba cilli. This study demonstrates that meropenem is a potent inhibitor of endotoxin release from gram-negative bacilli. With a high degree of a ntimicrobial activity, meropenem is effective against serious gram-neg ative infections and inhibits endotoxin release, in this way minimizin g endotoxin-mediated tissue damage.